8-K: Reeds Inc. Completes $9M Offering, Uplists to NYSE American

Reeds, Inc. successfully closed a public offering raising approximately $9.0 million and uplisted its common stock to the NYSE American, while also amending its corporate bylaws.

Summary

• Reeds, Inc. completed an underwritten public offering of 2,500,000 shares of common stock and 2,500,000 warrants to purchase common stock.
• The combined public offering price for one share of common stock and one accompanying warrant was $4.00.
• The underwriters partially exercised their 45-day overallotment option, purchasing an additional 375,000 warrants.
• The net proceeds to the company from the offering, including the partial exercise of the overallotment option, were approximately $9.0 million.
• The company's controlling stockholder, D&D Source of Life Holding Ltd., and its affiliated entities purchased approximately $5.0 million of securities in the offering.
• The common stock of Reeds, Inc. was approved for listing and began trading on the NYSE American on December 5, 2025, terminating its trading on the OTC Markets OTCQX Best Market.
• The company's Second Amended and Restated Bylaws became effective on December 5, 2025, introducing several corporate governance enhancements.
• Each warrant issued in the offering has an exercise price of $4.50 per share and is immediately exercisable, expiring on December 8, 2030.
• Warrants may be exercised cashlessly if no effective registration statement is available for the issuance of warrant shares.

Sentiment

Score: 8

Explanation: The sentiment is positive due to a successful capital raise providing significant funding for growth, a strategic uplisting to a major exchange (NYSE American) enhancing market presence, and strong participation from a controlling stockholder, indicating confidence.

Positives

• Successfully raised approximately $9.0 million in net proceeds from the public offering, strengthening the company's financial position.
• Uplisted common stock to the NYSE American, which typically enhances market visibility, liquidity, and investor confidence.
• Demonstrated strong insider confidence with the controlling stockholder, D&D Source of Life Holding Ltd., purchasing approximately $5.0 million of securities in the offering.
• The capital raise provides funding for growth initiatives, working capital, and other general corporate purposes, including potential debt repayment.

Negatives

• The issuance of warrants introduces potential future dilution for existing shareholders upon their exercise.
• Underwriting discounts and commissions, along with other offering expenses, reduced the gross proceeds from the offering.

Risks

• The enforceability of certain provisions in the warrant agreement, such as indemnification or limitations on liability, may be limited by applicable bankruptcy, insolvency, reorganization laws, general principles of equity, and public policy considerations.
• The availability of specific performance, injunctions, or other equitable remedies related to the warrants is subject to the discretion of the court.
• Warrant holders are subject to beneficial ownership limitations (initially 4.99% or 9.99% as elected) which restrict the number of shares they can acquire upon exercise.
• If the company fails to timely deliver warrant shares upon exercise, the holder may have rescission rights or compensation for 'Buy-In' costs, potentially incurring additional liabilities for the company.
• Warrant shares acquired upon exercise, if not registered and cashless exercise is not utilized, will have restrictions on resale imposed by state and federal securities laws.
• The company covenants to reserve sufficient authorized and unissued common stock for warrant exercise, but failure to do so could impair holder rights.

Future Outlook

The company intends to use the net proceeds from the offering, along with existing cash and cash equivalents, to fund growth initiatives, working capital, and other general corporate purposes, which may include debt repayment.

Management Comments

• Cyril Wallace, Chief Executive Officer, signed the Underwriting Agreement on behalf of Reeds, Inc.
• Douglas W. McCurdy, Chief Financial Officer, signed the Form 8-K on behalf of Reeds, Inc.

Industry Context

The uplisting to the NYSE American from the OTC Markets OTCQX Best Market signifies a move towards greater market legitimacy and potentially broader institutional investor appeal. This capital raise, coupled with enhanced corporate governance, positions the company for increased scrutiny and opportunities within its industry, aligning with trends of companies seeking more robust public market platforms for growth and capital access.

Comparison to Industry Standards

• NA

Corporate Governance

Related Party Transactions

• D&D Source of Life Holding Ltd., the controlling stockholder of the company, and its affiliated entities purchased approximately $5.0 million of securities issued in the public offering at the public offering price.

Stakeholder Impact

• Shareholders: Experience potential dilution from the issuance of new shares and warrants, but benefit from increased liquidity and visibility due to the NYSE American listing. Enhanced corporate governance may also provide long-term benefits.
• Company: Gains significant capital for growth and operational needs, improves its public market standing, and strengthens its balance sheet.
• Employees/Management: Benefit from a more stable and growth-oriented company, potentially with improved access to capital for strategic initiatives.
• Creditors: May see improved creditworthiness due to the capital raise and strengthened financial position.

Next Steps

• Apply net proceeds from the offering to fund growth initiatives, working capital, and other general corporate purposes, potentially including debt repayment.
• Maintain a transfer agent and warrant agent for the common stock and warrants.
• Comply with ongoing reporting requirements under the Exchange Act and Securities Act, including reporting the use of proceeds.
• Continue to retain an independent registered public accounting firm for at least three years or as required by regulations.
• Holders of warrants may exercise their purchase rights at an exercise price of $4.50 per share until December 8, 2030.

Key Dates

Keywords

Public Offering, NYSE American, Common Stock, Warrants, Capital Raise, Corporate Governance, SEC Filing, Underwriting Agreement, Equity Financing, Stock Exchange Listing